A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

NCT05358691 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The research was cancelled

Conditions

Lung Cancer Stage III

Interventions

DRUG: AN0025

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]